Want to Quit Smoking? This Study May Help

Research Center: Medical University of South Carolina
Location: 125 Doughty Street, Charleston, South Carolina
Lead Investigator: Dr. Michael Saladin
IRB Committee: This study has been reviewed and approved by the Medical University of South Carolina Institutional Review Board

Background

Recent research findings show that a medication known as Rapamycin – which is FDA-approved to treat organ rejection and some rare forms of lung disease – may also alter addiction-related memory in a way that decreases both the desire for drugs and drug use.

Therefore, the Medical University of South Carolina (MUSC) is conducting a related study to determine if Rapamycin can help in the treatment of smoking-related nicotine addiction.

This study seeks men and women who currently smoke and are looking to quit. Participants are required to attend 4 study visits at MUSC over a 3-week period; Participants will be compensated for participating in this study.

Why Participate? 

  • You may see a reduction in your urge to smoke and/or smoking.
  • You will receive appropriate professional referral depending on the outcome of your clinical assessment during study visits.
  • You will be compensated for participating in this study.
  • You will be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Men and women aged 18+ who currently smoke and want to quit smoking.
  • Able to attend 4 study visits at MUSC over approximately 3 weeks.
  • Have no history of drug or alcohol abuse.
  • Not currently undergoing smoking cessation treatments.

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial